Balyasny Asset Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$511K Buy
+149,373
New +$504K ﹤0.01% 2357
2025
Q3
Sell
-59,099
Closed -$350K 2896
2025
Q2
$350K Sell
59,099
-97,649
-62% -$562K ﹤0.01% 2430
2025
Q1
$1M Buy
+156,748
New +$1.51M ﹤0.01% 1987
2024
Q4
Sell
-106,133
Closed -$2.94M 2709
2024
Q3
$2.94M Buy
+106,133
New +$2.66M ﹤0.01% 1501
2024
Q1
Sell
-16,485
Closed -$260K 2605
2023
Q4
$260K Buy
+16,485
New +$170K ﹤0.01% 2225
2023
Q1
Sell
-429,901
Closed -$5.07M 2633
2022
Q4
$5.07M Buy
+429,901
New +$4.91M 0.01% 1019
2022
Q1
Sell
-83,568
Closed -$4.16M 2460
2021
Q4
$4.16M Buy
+83,568
New +$4.4M 0.01% 901

Other funds holding ASPN

Balyasny Asset Management's ASPN Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Aspen Aerogels (ASPN) in Q1 2026: 149,373 shares worth $511K. The stake represents ﹤0.01% of the portfolio and ranks #2357 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in ASPN as recently as Q2 2025.

Balyasny Asset Management first reported a position in ASPN in Q4 2021 and has held it in 7 quarters since. The position peaked at $5.07M in Q4 2022. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Balyasny Asset Management held 149,373 shares of Aspen Aerogels worth $511K as of Q1 2026.
  • Aspen Aerogels was a new Balyasny Asset Management position in Q1 2026.
  • Aspen Aerogels made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2357 holding.
  • Balyasny Asset Management first reported a position in Aspen Aerogels in Q4 2021 and has held it in 7 quarters since.
  • Balyasny Asset Management's Aspen Aerogels position peaked at $5.07M in Q4 2022.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.